CLINICAL_TRIALS
trial_result
· 2013-09-04
Clinical Trial Update: Panitumumab and Irinotecan for Malignant Gliomas [Phase 2]
Summary
Phase 2 trial evaluating panitumumab in combination with irinotecan for malignant glioma was terminated with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Annick Desjardins | Conditions: Malignant Glioma of Brain | Phase 2 | Status: TERMINATED | Results posted: 2013-09-04